Janusz Krawczyk

902 total citations
51 papers, 548 citations indexed

About

Janusz Krawczyk is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Janusz Krawczyk has authored 51 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Hematology and 12 papers in Genetics. Recurrent topics in Janusz Krawczyk's work include Multiple Myeloma Research and Treatments (12 papers), Pluripotent Stem Cells Research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Janusz Krawczyk is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Pluripotent Stem Cells Research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Janusz Krawczyk collaborates with scholars based in Ireland, China and United Kingdom. Janusz Krawczyk's co-authors include Michael O’Dwyer, Niamh Keane, Veronica McInerney, Sanbing Shen, Siobhán Glavey, Mark E. Gurney, Timothy O’Brien, Ronan Swords, Ciara L. Freeman and Aideen E. Ryan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Janusz Krawczyk

47 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janusz Krawczyk Ireland 13 266 121 102 82 69 51 548
Samiksha Wasnik United States 14 161 0.6× 77 0.6× 74 0.7× 101 1.2× 97 1.4× 31 521
Yougen Xi United States 9 442 1.7× 83 0.7× 174 1.7× 68 0.8× 86 1.2× 9 767
Xiao–Tang Kong United States 12 339 1.3× 94 0.8× 190 1.9× 109 1.3× 180 2.6× 51 679
Thusanth Thuraisingam Canada 14 202 0.8× 66 0.5× 92 0.9× 209 2.5× 158 2.3× 25 698
Keith M. Blechman United States 9 285 1.1× 63 0.5× 97 1.0× 72 0.9× 60 0.9× 13 807
Susann Pankratz Germany 15 179 0.7× 106 0.9× 133 1.3× 319 3.9× 93 1.3× 27 728
Dalia Arafat United States 13 233 0.9× 46 0.4× 74 0.7× 133 1.6× 218 3.2× 24 612
Hidetoshi Tsushima Japan 17 246 0.9× 94 0.8× 84 0.8× 114 1.4× 58 0.8× 49 687

Countries citing papers authored by Janusz Krawczyk

Since Specialization
Citations

This map shows the geographic impact of Janusz Krawczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janusz Krawczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janusz Krawczyk more than expected).

Fields of papers citing papers by Janusz Krawczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janusz Krawczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janusz Krawczyk. The network helps show where Janusz Krawczyk may publish in the future.

Co-authorship network of co-authors of Janusz Krawczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Janusz Krawczyk. A scholar is included among the top collaborators of Janusz Krawczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janusz Krawczyk. Janusz Krawczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cormican, Sarah, Shirley Hanley, Md Nahidul Islam, et al.. (2025). Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations. Stem Cells Translational Medicine. 14(6).
2.
Swan, Dawn, Robert B. Henderson, John Quinn, et al.. (2022). CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment. Clinical Lymphoma Myeloma & Leukemia. 22(11). 847–852. 1 indexed citations
3.
Gurney, Mark E., Sarah Corcoran, Sarah Brophy, et al.. (2022). Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor–natural killer cells. Cytotherapy. 24(11). 1087–1094. 22 indexed citations
4.
Krawczyk, Janusz, et al.. (2022). MiRNA as a Potential Target for Multiple Myeloma Therapy–Current Knowledge and Perspectives. Journal of Personalized Medicine. 12(9). 1428–1428. 6 indexed citations
5.
Bogdanet, Delia, Md Nahidul Islam, Tomás P. Griffin, et al.. (2022). Reference intervals for clinical biochemistry and haematology tests during normal pregnancy. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 59(6). 433–446. 5 indexed citations
6.
7.
Hanahoe, Belinda, et al.. (2022). Case of recurrent Achromobacter xylosoxidans bacteraemia and PICC (peripherally-inserted central catheter) line infection in an immunocompromised patient. Infection Prevention in Practice. 4(1). 100202–100202. 5 indexed citations
8.
Szczyrek, Michał, et al.. (2021). Therapeutic Potential of Innate Lymphoid Cells for Multiple Myeloma Therapy. Cancers. 13(19). 4806–4806. 6 indexed citations
9.
Liu, Min, Ning Ge, Jianhua Zhang, et al.. (2021). Derivation and characterization of two human induced pluripotent stem cell lines (NUIGi004-A) and (NUIGi012-A) from two patients with LQT2 disease. Stem Cell Research. 56. 102555–102555. 1 indexed citations
10.
Mlak, Radosław, Michał Mielnik, Iwona Homa‐Mlak, et al.. (2020). Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients. British Journal of Haematology. 191(1). 77–89. 18 indexed citations
11.
Howard, Linda, Veronica McInerney, Janusz Krawczyk, et al.. (2020). Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities. Cytotherapy. 22(6). 313–321. 26 indexed citations
12.
13.
Ge, Ning, Min Liu, Xiaoran Zhu, et al.. (2020). Generation and characterization of two induced pluripotent stem cell lines (NUIGi038-A, NUIGi038-B) from dermal fibroblasts of a healthy individual. Stem Cell Research. 49. 101996–101996. 3 indexed citations
14.
15.
16.
Daly, J.M., Jinsong Hu, Alessandro Natoni, et al.. (2017). Targeting Siglec-7: A Novel Immunotherapeutic Approach to Potentiate the Cytotoxic Functions of Natural Killer Cells Against Multiple Myeloma. Blood. 130. 1799–1799. 3 indexed citations
17.
Krawczyk, Janusz, et al.. (2017). New developments in the treatment of multiple myeloma &ndash; <br />clinical utility of daratumumab. Biologics. Volume 11. 31–43. 6 indexed citations
18.
Sotthibundhu, Areechun, Alex von Kriegsheim, Amaya García-Muñoz, et al.. (2016). Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cells. Stem Cell Research & Therapy. 7(1). 166–166. 75 indexed citations
19.
20.
Krawczyk, Janusz, Ronan Swords, Tracy Murphy, et al.. (2009). Clofarabine in the treatment of poor risk acute myeloid leukaemia. Hematological Oncology. 28(3). 118–123. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samiksha Wasnik Breakdown of academic impact, for papers by Yougen Xi Breakdown of academic impact, for papers by Xiao–Tang Kong Breakdown of academic impact, for papers by Thusanth Thuraisingam Breakdown of academic impact, for papers by Keith M. Blechman Breakdown of academic impact, for papers by Susann Pankratz Breakdown of academic impact, for papers by Dalia Arafat Breakdown of academic impact, for papers by Hidetoshi Tsushima
Rankless by CCL
2026